Biotechnology

Filter

Current filters:

None

Popular Filters

1 to 25 of 2384 results

Specialised Therapeutics' Abraxane to be reimbursed via Australian PBS

Specialised Therapeutics' Abraxane to be reimbursed via Australian PBS

31-10-2014

Australian biopharma company Specialised Therapeutics is to have its Abraxane (nanoparticle albumin-bound…

AbraxaneAustraliaBiotechnologyOncologyRegulationSpecialised Therapeutics Australia

Department of Defense contracts Profectus to develop its VesiculoVax Zaire-Ebola virus vaccine

Department of Defense contracts Profectus to develop its VesiculoVax Zaire-Ebola virus vaccine

31-10-2014

The US Department of Defense has contracted the manufacture and IND-enabling preclinical testing of the…

Anti-viralsBiotechnologyProfectus BioSciencesResearchUSAVesiculoVax Zaire-Ebola

Affinivax launches, aiming to develop novel conjugate vaccine

30-10-2014

Affinivax, a US biotechnology company dedicated to developing novel vaccines, today announced its launch…

AffinivaxBiotechnologyFinancialResearchVaccines

EMA guidance on facilitating global development of biosimilars

EMA guidance on facilitating global development of biosimilars

30-10-2014

The European Medicines Agency has published its revised overarching guideline on biosimilars, or follow-on…

BiosimilarsBiotechnologyEuropeRegulation

SOBI increases revenues by 25%, boosted by a doubling of Orfadin sales

SOBI increases revenues by 25%, boosted by a doubling of Orfadin sales

30-10-2014

Biotech firm Swedish Orphan Biovitrum has announced total revenues of 665.9 million Swedish kronor ($99.8…

BiotechnologyBusiness FinanceOrfadinSobiSweden

Xencor regains rights to XmAb5871 from Amgen

29-10-2014

US drug developer Xencor revealed yesterday that it has regained all development and commercial rights…

AmgenAnti-Arthritics/RheumaticsBiotechnologyImmunologicalsLicensingResearchXencorXmAb5871

Synthetic Genomics appoints Oliver Fetzer as chief executive

Synthetic Genomics appoints Oliver Fetzer as chief executive

29-10-2014

Synthetic biology company Synthetic Genomics has appointed Oliver Fetzer as the company’s new chief…

BiotechnologyBoardroomSGISynthetic GenomicsUSA

Gilead third-qtr sales beat expectations, but Sovaldi disappoints

Gilead third-qtr sales beat expectations, but Sovaldi disappoints

29-10-2014

There was mixed news late yesterday from US anti-virals major Gilead Sciences, when the biotech posted…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldiUSA

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Licensing deal index shows re-emergence of late-stage deals

Licensing deal index shows re-emergence of late-stage deals

28-10-2014

Licensing deals among biotech companies have recently shown a healthy surge, especially in later stages.

BiotechnologyCelgene Corp.FinancialLicensingMorrisonUK

Despite restructuring costs, Amgen’s third-qtr beats expectations

Despite restructuring costs, Amgen’s third-qtr beats expectations

28-10-2014

US biotech major Amgen posted a fall in earnings for the third-quarter of 2014, due to restructuring,…

AmgenBiotechnologyFinancialThousand Oaks, CaliforniaUSA

Takeda licenses commercial rights to Mersana Fleximer-ADC

27-10-2014

Just seven months after the collaboration was announced, Japan’s largest drugmaker Takeda Pharmaceutical…

BiotechnologyFleximerLicensingMersana TherapeuticsMillennium PharmaceuticalsOncologyTakeda Pharmaceutical

EuropaBio’s new White Paper 'Realising the Potential of Personalized Medicine in Europe'

27-10-2014

Biotechnology trade group EuropaBio has issued a new White Paper, aiming to identify the required adaptations…

BiotechnologyEuropeRegulationResearch

GSK expands collaboration with Five Prime Therapeutics

GSK expands collaboration with Five Prime Therapeutics

27-10-2014

US biotech firm Five Prime Therapeutics is expanding its respiratory disease research collaboration with…

BiotechnologyFive Prime TherapeuticsGlaxoSmithKlineLicensingResearchRespiratory and Pulmonary

Octapharma mulls building hemophilia product plant in Russia

27-10-2014

Independent Swiss biotech company Octapharma is considering building a plant for production of drugs…

BiotechnologyHematologyOctapharmaProductionRussia

CTI acquires tosedostat rights from Vernalis and Chroma

CTI acquires tosedostat rights from Vernalis and Chroma

27-10-2014

Blood-related cancer specialist CTI BioPharma has acquired the worldwide rights to tosedostat through…

BiotechnologyChroma TherapeuticsCTI BioPharmaLicensingOncologytosedostatUSAVernalis

WuXi PharmaTech collaborates on genomic profiling for China

24-10-2014

China’s WuXi PharmaTech has entered into a collaboration with USA-based Foundation Medicine to offer…

BiotechnologyChinaFoundation MedicineLicensingOncologyWuXi PharmaTech

Celgene third-quarter results beat estimates; ups guidance

Celgene third-quarter results beat estimates; ups guidance

23-10-2014

US biotech major Celgene today reported better-than-expected financial results, with net product sales…

BiotechnologyCelgene Corp.Celgene Corp.FinancialUnited StatesUSA

Sutro Biopharma and Celgene expand accord; add buyout option

23-10-2014

Sutro Biopharma today announced it has entered into a strategic collaboration and option agreement with…

BiotechnologyCelgene Corp.LicensingMergers & AcquisitionsOncologySutro Biopharma

Discussion launched about the future of biosimilars in Italy

Discussion launched about the future of biosimilars in Italy

23-10-2014

Results from a survey of 470 European physicians conducted by the Alliance for Safe Biologic Medicines…

BiosimilarBiosimilarsBiotechnologyItalyRegulation

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

Harvoni will keep Gilead atop hepatitis C treatment landscape, says analyst

23-10-2014

The recent US Food and Drug Administration approval of Harvoni (ledipasvir/sofosbuvir), Gilead Sciences’…

Anti-viralsBiotechnologyGilead SciencesHarvoniMarkets & MarketingPricingSovaldiUSA

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

Cardio3 Biosciences appoints Warren Sherman as chief medical officer

23-10-2014

Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed…

BelgiumBiotechnologyBoardroomCardio3 BioSciencesCardio3 BioSciences

1 to 25 of 2384 results

Parexel

Parexel

Back to top